Additional Resources

Section

NORD rare disease drug development ad.

Get Information about a Rare Disease

Use the form below to explore NORD's comprehensive rare disease database. Search for detailed information on rare diseases, including NORD's authoritative Rare Disease Reports and data from other reliable sources.
* = NORD Rare Disease Report

Interested in exploring the database in detail?
Click here to explore the database in alphabetical order.

NORD Summit 2026 Banner Ad

acute myeloid leukemia with 11q23 abnormalities

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Connect & Download

Disease Overview

An acute myeloid leukemia associated with t(9;11)(p22.3;q23.3) and MLLT3-KMT2A fusion protein expression. Morphologically it usually has monocytic features. It may present at any age but it is more commonly seen in children. Patients may present with disseminated intravascular coagulation.

Synonyms

  • AML with 11q23 abnormalities
  • AML with t(9;11)(p22;q23); MLLT3-MLL
  • acute myeloid Leukaemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
  • acute myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A
  • acute myeloid leukaemia with 11q23 (MLL) abnormalities
  • acute myeloid leukaemia with MLL abnormalities
  • acute myeloid leukaemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • acute myeloid leukaemia with t(9;11)(p22;q23); MLLT3-MLL
  • acute myeloid leukemia with 11q23 (MLL) abnormalities
  • acute myeloid leukemia with MLL abnormalities
  • acute myeloid leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL
GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
Sign Up for NORD News

Access State Report Card Data

Please complete this form to access the requested resource.

Please consider sharing some basic information with us.

Name(Required)
Consent(Required)
This field is hidden when viewing the form